Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise value
Mamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This strategic move, Honasa's second acquisition in under a year, signals a growing trend of consolidation in the beauty and personal care sector. Honasa aims to integrate science-backed skincare with nutraceuticals, addressing consumer demand for holistic wellness solutions. Fluence Pharma will become the ninth brand under Honasa's umbrella.
RSS News
Economic times
0 thoughts on “Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise value”
Leave a Reply
Your email address will not be published. Required fields are marked *
RECENT NEWS
- 'Fake news alert,' US envoy, Piyush Goyal dismiss media report that India rejected quick trade deal
- 'I will commit suicide': What Manmohan Singh told then-CEC SY Quraishi over 'loose talks' by ministers
- Road rage | Politics of renaming a street in Bengal
- Sainik School hosts motivational talk on globe circumnavigation and Everest expedition
- FIFA World Cup 2026: Argentina win in extra time, Messi's team reaches semi-finals
